![Douglas Farrell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Douglas Farrell
Corporate Officer/Principal presso NIRI NY Chapter
Profilo
Douglas Farrell is a Member at NIRI NY Chapter since 1998.
He previously worked as a Senior Director-Investor Relations at The Liposome Co., Inc., Aurora Biosciences Corp., and Genentech, Inc. He also served as a Vice President-Investor Relations at Affymetrix, Inc. from 2012 to 2013 and as a VP-Investor Relations & Corporate Communications at NanoString Technologies, Inc. Mr. Farrell completed his undergraduate degree at Northeastern University.
Posizioni attive di Douglas Farrell
Società | Posizione | Inizio |
---|---|---|
NIRI NY Chapter | Corporate Officer/Principal | 01/01/1998 |
Precedenti posizioni note di Douglas Farrell
Società | Posizione | Fine |
---|---|---|
NS WIND DOWN CO., INC. | Contatto Relazioni con gli Investitori | 26/06/2024 |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
The Liposome Co., Inc.
![]() The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Contatto Relazioni con gli Investitori | - |
Aurora Biosciences Corp.
![]() Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Contatto Relazioni con gli Investitori | - |
AFFYMETRIX, INC. | Contatto Relazioni con gli Investitori | - |
Formazione di Douglas Farrell
Northeastern University | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Società quotate in Borsa | 1 |
---|---|
NS WIND DOWN CO., INC. | Health Technology |
Aziende private | 5 |
---|---|
Affymetrix, Inc.
![]() Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Aurora Biosciences Corp.
![]() Aurora Biosciences Corp. BiotechnologyHealth Technology Aurora Biosciences Corp. designs and develops proprietary drug discovery systems, services and technologies to the discovery of new medicine. It develops a proprietary ultra-high throughput screening platform that uniquely integrates innovative fluorescence chemistry, molecular biology, miniaturization, automation, and informatics. The company also provides assay development and screening services. Aurora was founded in 1995 and is located in San Diego, CA. | Health Technology |
The Liposome Co., Inc.
![]() The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology The Liposome Co., Inc. is a biopharmaceutical company engaged in the discovery, development, manufacturing and marketing of proprietary lipid- and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. | Health Technology |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
NIRI NY Chapter |
- Borsa valori
- Insiders
- Douglas Farrell